Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Movemed Limited maintains 1 pending office action in the Medical Devices & Mechanical Engineering sector. Prosecution is currently limited to a distinct examiner and a distinct art unit, indicating a focused presence in the patent system. This structure allows for a direct and singular focus on the examiner's specific requirements without the complexity of managing multiple art units or varying examiner preferences. The concentration in a distinct art unit suggests that the company's intellectual property strategy is focused on a specific technical niche within its field.
The busiest examiner, TU, AURELIE H, holds 1 busiest examiner pending office action. This represents the full extent of the total pending office actions. For Movemed Limited, the path to allowance or further prosecution depends entirely on the interactions with this individual. The lack of diversity in examiners and art units suggests that the current legal strategy is consolidated around a specific technological thread. Practitioners should note that successful negotiation with TU, AURELIE H is critical, as there are no other active applications to offset a negative outcome in this matter.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TU, AURELIE H | 1 | 56.4% | +60.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18037989 | SYSTEM AND METHOD FOR ASSESSING NEUROMUSCULAR DISEASE | TU, AURELIE H | 77d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18037989 | SYSTEM AND METHOD FOR ASSESSING NEUROMUSCULAR DISEASE | TU, AURELIE H | 77d |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18037989 | SYSTEM AND METHOD FOR ASSESSING NEUROMUSCULAR DISEASE | TU, AURELIE H | 3791 | §101§103 | Non-Final OA | 77d | Pending | May 19, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial